Taken together, our results suggest that substantial short-term weight loss can restore glucose homeostasis in individuals with severe obesity and NFG, IFG, and recent-onset T2DM not treated with insulin, with greater benefits accruing to those with less severe abnormalities of glucose metabolism. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.